Company Profile for Acucela Inc.

--()--Acucela Inc., is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Acucela’s development pipeline include drug candidates and therapeutics for the treatment of retinitis pigmentosa, proliferative diabetic retinopathy, diabetic macular edema, AMD, Stargardt disease, cataracts and presbyopia. The company is also developing a monitoring device for neovascular retinal diseases, to be used directly by patients.

 
Company:   Acucela Inc.
 
Headquarters Address: 818 Stewart St., Suite 1110
Seattle, WA 98101
 
Main Telephone:

1-206-805-8300

 
Website:

www.acucela.com

 
Type of Organization: Private
 

Industry:

Biotechnology, Medical Devices, Pharmaceutical

 
Key Executives: CEO: Ryo Kubota, MD, PhD
 
Public Relations
Contact: Michael Hasegawa
Phone:

+81-3-6550-8928

Email:

mhasegawa@acucela.com

 
Investor Relations
Contact: John Gebhart
Phone: +1-206-805-3972
Email:

jgebhart@acucela.com